Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03314181 |
|---|---|
| Brief Title: | A Study of Combination Therapy With Venetoclax, Daratumumab and Dexamethasone (With and Without Bortezomib) in Participants With Relapsed or Refractory Multiple Myeloma |
| First Submitted : | October 11, 2017 |
| First Submitted that Met QC Criteria : | October 17, 2017 |
| First Posted : | October 19, 2017 |
| Last Update Submitted that Met QC Criteria : | February 14, 2023 |
| Last Update Posted : | February 16, 2023 |